Skip to main content
GNI Group Ltd. logo

GNI Group Ltd. — Investor Relations & Filings

Ticker · 2160 ISIN · JP3386370005 LEI · 5299005KSTCN0WVJMQ52 T Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2025-03-31 Governance Information
Country JP Japan
Listing T 2160

About GNI Group Ltd.

https://www.gnipharma.com/

GNI Group Ltd. is a vertically integrated, multinational biopharmaceutical company engaged in the full spectrum of drug development, from research and clinical trials to manufacturing, sales, and marketing. The company's portfolio includes pharmaceutical drugs, traditional Chinese medicines, and medical devices. Its research and development efforts are primarily focused on creating therapies for diseases such as cancer and inflammation, with a particular emphasis on conditions prevalent in Asian populations. The group utilizes genetic information and analysis technology to advance its drug discovery programs.

Recent filings

Filing Released Lang Actions
内部統制報告書－第24期(2024/01/01－2024/12/31)
Governance Information Classification · 100% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). It details the scope, criteria, and procedures for evaluating internal controls over financial reporting, concluding with an assessment of their effectiveness as of the fiscal year-end (2024年12月31日). This structure is characteristic of the Japanese equivalent of the Sarbanes-Oxley Section 404 report on internal controls over financial reporting. While the provided definitions do not have a direct code for the Japanese 'Internal Control Report,' the closest functional equivalent among the choices, based on the content focusing on internal controls and financial reporting integrity, is the Audit Report/Information (AR), as it deals with the assurance and structure surrounding financial reporting, although it is distinct from a standard external audit opinion. However, given the specific nature of this filing (Internal Control Report under Japanese law), and the lack of a perfect match, I must re-evaluate the provided codes. None of the codes (10-K, AR, IR, etc.) perfectly map to a standalone Internal Control Report (which is often filed alongside the 10-K equivalent in Japan, the Yuka Shoken Hokokusho). Since this document focuses entirely on the *assessment* of internal controls for financial reporting, and 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests,' it is the most plausible fit among the limited options for a document focused on internal control assurance, even if it's not strictly an external audit report. Given the highly specific nature of the document (Internal Control Report), and the absence of a dedicated code, I will select the closest regulatory/assurance document type, which is AR.
2025-03-31 Japanese
有価証券報告書－第24期(2024/01/01－2024/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, for the fiscal year ending December 31, 2024. This aligns with the definition of an Annual Report (10-K equivalent). FY 2024
2025-03-31 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because resolutions were passed at the "第24回定時株主総会" (24th Annual General Meeting) held on March 27, 2025. Section 2 details the resolution regarding the election of seven directors. This content—reporting the results of a shareholder vote at an AGM—directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the primary focus is reporting the *results* of the vote, not the presentation materials (AGM-R) or the proxy solicitation (PSI). The document is a formal regulatory filing reporting specific voting outcomes.
2025-03-28 Japanese
臨時報告書
Regulatory Filings Classification · 95% confidence The document is explicitly titled "臨時報告書" (Extraordinary Report or Timely Disclosure Report) and is filed with the Kanto Local Finance Bureau Director ("関東財務局長"). The filing reason states that the company is submitting this report based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act because certain events (stock valuation loss and foreign exchange loss) have a significant impact on the company's financial condition, operating results, and cash flows. This structure and legal basis strongly indicate a mandatory, unscheduled disclosure required by Japanese securities regulations for material events. Since it is not a standard periodic report (like 10-K or IR), nor a specific announcement like a dividend or management change, and it serves as a general regulatory disclosure for a significant event, the most appropriate general category for such mandatory, non-standard filings in this context is 'Regulatory Filings' (RNS), as it functions as a catch-all for required disclosures that don't fit the more specific categories like ER or DIV. The document length is very short (1210 chars), suggesting it is the announcement itself, not the detailed underlying report.
2024-08-14 Japanese
半期報告書－第24期(2024/01/01－2024/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for GNI Group Ltd., covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial statements, management analysis (MDA), and operational updates, which are characteristic of an interim financial report. It is not a mere announcement or certification, as it provides comprehensive financial data and analysis. H1 2024
2024-08-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the title "第２四半期報告書" (Second Quarter Report) and explicitly mentions the period covered: "第24期中間期（自2024年１月１日 至2024年６月30日）" (24th Fiscal Period Interim Period (January 1, 2024, to June 30, 2024)). It also includes a confirmation statement regarding the appropriateness of the contents of the '半期報告書' (Interim Report) as per financial instruments laws, signed by the CEO and CFO. This structure strongly indicates a comprehensive financial report for a period shorter than a year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). The document length is short (630 chars), but the content is the substance of the report confirmation, not just an announcement of publication, making IR more accurate than RPA or RNS.
2024-08-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.